BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9533061)

  • 1. Clostridium difficile toxin-induced colitis after use of clindamycin phosphate vaginal cream.
    Meadowcroft AM; Diaz PR; Latham GS
    Ann Pharmacother; 1998 Mar; 32(3):309-11. PubMed ID: 9533061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fulminant pseudomembranous colitis caused by clindamycin phosphate vaginal cream.
    Trexler MF; Fraser TG; Jones MP
    Am J Gastroenterol; 1997 Nov; 92(11):2112-3. PubMed ID: 9362204
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium difficile-associated diarrhea after short term vaginal administration of clindamycin.
    Vikenes K; Lund-Tønnesen S; Schreiner A
    Am J Gastroenterol; 1999 Jul; 94(7):1969-70. PubMed ID: 10406271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis.
    McCormack WM; Covino JM; Thomason JL; Eschenbach DA; Mou S; Kapernick P; McGregor J; Rein MF; Hillier SL
    Sex Transm Dis; 2001 Oct; 28(10):569-75. PubMed ID: 11689755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures.
    Bombassaro AM; Wetmore SJ; John MA
    J Can Dent Assoc; 2001 Jan; 67(1):20-2. PubMed ID: 11209501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.
    Sobel J; Peipert JF; McGregor JA; Livengood C; Martin M; Robbins J; Wajszczuk CP
    Infect Dis Obstet Gynecol; 2001; 9(1):9-15. PubMed ID: 11368263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects.
    George WL
    Rev Infect Dis; 1984; 6 Suppl 1():S208-13. PubMed ID: 6372031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomembranous colitis caused by topical clindamycin phosphate.
    Parry MF; Rha CK
    Arch Dermatol; 1986 May; 122(5):583-4. PubMed ID: 2939805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
    Tunçcan OG; Ulutan F; Karakuş R
    Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomembranous colitis after topical application of clindamycin.
    Milstone EB; McDonald AJ; Scholhamer CF
    Arch Dermatol; 1981 Mar; 117(3):154-5. PubMed ID: 6452096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of diarrhea and Clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, beta-lactams, or nonantibiotic medications.
    Thamlikitkul V; Danpakdi K; Chokloikaew S
    J Clin Gastroenterol; 1996 Mar; 22(2):161-3. PubMed ID: 8742665
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis.
    Faro S; Skokos CK;
    Infect Dis Obstet Gynecol; 2005 Sep; 13(3):155-60. PubMed ID: 16240515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Six years evaluation of Clostridium difficile associated diarrhea].
    Ercis S; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Clostridium difficile enterocolitis in foals.
    Arroyo LG; Weese JS; Staempfli HR
    J Vet Intern Med; 2004; 18(5):734-8. PubMed ID: 15515592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis.
    Minozzi M; Gerli S; Di Renzo GC; Papaleo E; Ferrari A
    Eur Rev Med Pharmacol Sci; 2008; 12(1):59-65. PubMed ID: 18401974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.